McKesson Pre-Paid Expenses 2010-2024 | MCK

McKesson pre-paid expenses from 2010 to 2024. Pre-paid expenses can be defined as a current asset created by prepayment of costs and expenses for which the benefits will occur at a future date.
  • McKesson pre-paid expenses for the quarter ending September 30, 2024 were $0.636B, a 19.32% increase year-over-year.
  • McKesson pre-paid expenses for 2024 were $0.626B, a 22.03% increase from 2023.
  • McKesson pre-paid expenses for 2023 were $0.513B, a 42.87% decline from 2022.
  • McKesson pre-paid expenses for 2022 were $0.898B, a 35.04% increase from 2021.
McKesson Annual Pre-Paid Expenses
(Millions of US $)
2024 $626
2023 $513
2022 $898
2021 $665
2020 $617
2019 $529
2018 $443
2017 $672
2016 $1,072
2015 $1,119
2014 $1,877
2013 $404
2012 $404
2011 $333
2010 $257
2009 $261
McKesson Quarterly Pre-Paid Expenses
(Millions of US $)
2024-06-30 $636
2024-03-31 $626
2023-12-31 $572
2023-09-30 $568
2023-06-30 $533
2023-03-31 $513
2022-12-31 $675
2022-09-30 $722
2022-06-30 $590
2022-03-31 $898
2021-12-31 $831
2021-09-30 $861
2021-06-30 $706
2021-03-31 $665
2020-12-31 $688
2020-09-30 $701
2020-06-30 $850
2020-03-31 $617
2019-12-31 $618
2019-09-30 $657
2019-06-30 $590
2019-03-31 $529
2018-12-31 $587
2018-09-30 $542
2018-06-30 $558
2018-03-31 $443
2017-12-31 $458
2017-09-30 $719
2017-06-30 $728
2017-03-31 $672
2016-12-31 $513
2016-09-30 $526
2016-06-30 $545
2016-03-31 $1,072
2015-12-31 $1,042
2015-09-30 $1,005
2015-06-30 $1,320
2015-03-31 $1,119
2014-12-31 $595
2014-09-30 $621
2014-06-30 $824
2014-03-31 $1,877
2013-12-31 $591
2013-09-30 $780
2013-06-30 $817
2013-03-31 $404
2012-12-31 $361
2012-09-30 $367
2012-06-30 $418
2012-03-31 $404
2011-12-31 $329
2011-09-30 $368
2011-06-30 $356
2011-03-31 $333
2010-12-31 $286
2010-09-30 $256
2010-06-30 $265
2010-03-31 $257
2009-12-31 $265
2009-09-30 $279
2009-06-30 $271
2009-03-31 $261
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $79.492B $308.951B
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $66.954B 17.60
Cardinal Health (CAH) United States $29.177B 15.82
West Pharmaceutical Services (WST) United States $23.472B 47.94
Cooper (COO) United States $20.662B 29.41
Labcorp (LH) United States $20.273B 16.81
Align Technology (ALGN) United States $16.462B 31.50
Henry Schein (HSIC) United States $8.478B 16.15
Merit Medical Systems (MMSI) United States $5.988B 30.58
DENTSPLY SIRONA (XRAY) United States $3.620B 9.65
CONMED (CNMD) United States $2.268B 18.93
Patterson (PDCO) United States $1.833B 9.67
STAAR Surgical (STAA) United States $1.458B 53.80
Lifevantage (LFVN) United States $0.171B 22.77
Pro-Dex (PDEX) United States $0.139B 27.71